News
Market Data
Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.
The current EVLO market cap is 65.92M. The company's latest EPS is -6.08 and P/E is -0.60.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -58.1M | -86.36M | -91.89M | -115.4M | -108.47M |
| Net Income | -60.88M | -85.47M | -93.67M | -122.18M | -114.53M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 159.87M | 90.92M | 90.64M | 87.87M | 64.44M |
| Total Liabilities | 22.92M | 30.72M | 60.15M | 79.2M | 69.43M |
| Total Equity | 136.95M | 60.2M | 30.49M | 8.67M | -4.99M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -47.28M | -71.98M | -73.06M | -96.73M | -101.24M |
| Investing | -60.13M | 51.97M | -1.32M | -1.48M | -622k |
| Financing | 162.01M | 4.99M | 65.47M | 97.54M | 81.66M |
| Market Cap | 65.92M |
| Price to Earnings Ratio | -0.60 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.43 |
| Price to Book Ratio | -13.73 |
| Dividend Yield | - |
| Shares Outstanding | 18.84M |
| Average Volume (1 week) | 72.72k |
| Average Volume (1 Month) | 108.31k |
| 52 Week Change | -90.33% |
| 52 Week High | 48.40 |
| 52 Week Low | 1.586 |
| Spread (Intraday) | 0.4 (10.5%) |
| Company Name | Evelo Biosciences Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.evelobio.com |
| Industry | pharmaceutical preparations (2834) |
